Inactive Instrument
Protide Pharmaceuticals, Inc. Stock Other OTC
Stocks
PPMD
US74371A1034
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -75.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CEO | Chief Executive Officer | 70 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CHM | Chairman | 70 | 18/02/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -75.00% | -75.00% | - | - | 886K | |
| -2.01% | -7.86% | +54.60% | +70.97% | 70.44B | |
| +3.84% | -11.02% | +8.59% | +58.77% | 50.31B | |
| +3.35% | +1.42% | +11.85% | +37.39% | 47.51B | |
| +0.90% | +1.62% | +28.10% | +31.82% | 42.91B | |
| +3.01% | -2.95% | +310.40% | +471.34% | 40.39B | |
| +0.93% | -3.15% | +9.85% | +102.69% | 39.69B | |
| +0.06% | -1.43% | +10.47% | +43.27% | 30.59B | |
| -2.95% | -14.09% | +37.94% | +1.30% | 26.8B | |
| +0.17% | -6.57% | -13.27% | -8.23% | 22.36B | |
| Average | -6.78% | -5.58% | +50.95% | +89.92% | 41.22B | |
| Weighted average by Cap. | +0.89% | -5.44% | +53.95% | +95.38% |
Employees
-
